We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

79 hedge funds and large institutions have $156M invested in Avadel Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 25 increasing their positions, 19 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 15

32% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 19

23% more call options, than puts

Call options by funds: $1.12M | Put options by funds: $907K

7% more funds holding

Funds holding: 74 → 79 (+5)

8.23% less ownership

Funds ownership: 62.4% → 54.17% (-8.2%)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

47% less capital invested

Capital invested by funds: $293M → $156M (-$137M)

Holders
79
Holders Change
+5
Holders Change %
+6.76%
% of All Funds
1.59%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
20
Increased
25
Reduced
19
Closed
15
Calls
$1.12M
Puts
$907K
Net Calls
+$211K
Net Calls Change
-$3.02M

Top Buyers

Rank Fund Capital Flow
1
BIP
Brandes Investment Partners
California
+$9.87M
2
PVI
Pura Vida Investments
New York
+$1.69M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.61M
4
Morgan Stanley
Morgan Stanley
New York
+$1.38M
5
Millennium Management
Millennium Management
New York
+$1.12M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$25.3M
2
VA
VR Adviser
New York
-$8.55M
3
ACP
Acuta Capital Partners
California
-$7.62M
4
APM
Avidity Partners Management
Texas
-$3.7M
5
IC
Ikarian Capital
Texas
-$3.15M
Name Holding Trade Value Shares
Change 		Change in
Stake
KP
26
Keel Point
Alabama
$465K +$146K +20,000 +28%
CS
27
Candriam SCA
Luxembourg
$428K – – –
CM
28
Caption Management
Oklahoma
$427K +$616K +84,600 New
State Street
29
State Street
Massachusetts
$417K +$468K +64,256 +347%
Citadel Advisors
30
Citadel Advisors
Florida
$363K +$160K +21,947 +44%
CSS
31
Cubist Systematic Strategies
Connecticut
$347K +$501K +68,820 New
CIBC Private Wealth Group
32
CIBC Private Wealth Group
Georgia
$328K +$473K +65,005 New
Squarepoint
33
Squarepoint
New York
$308K +$445K +61,165 New
SC
34
Schulhoff & Co
Ohio
$307K +$444K +61,000 New
EWM
35
Edge Wealth Management
New York
$302K +$437K +60,000 New
HS
36
HighVista Strategies
Massachusetts
$290K +$44.3K +6,087 +12%
IC
37
Ikarian Capital
Texas
$275K -$3.15M -432,449 -89%
IAMOG
38
Investors Asset Management of Georgia
Georgia
$269K +$125K +17,125 +47%
ECM
39
ExodusPoint Capital Management
New York
$236K +$340K +46,731 New
Group One Trading
40
Group One Trading
Illinois
$234K +$338K +46,443 New
Geode Capital Management
41
Geode Capital Management
Massachusetts
$174K +$52.1K +7,157 +26%
EVM
42
Eaton Vance Management
Massachusetts
$162K – – –
OC
43
Oppenheimer & Co
New York
$141K +$37K +5,090 +22%
QSS
44
Quantitative Systematic Strategies
Florida
$139K +$3.16K +434 +2%
DTL
45
Dynamic Technology Lab
Singapore
$133K -$128K -17,598 -40%
EGM
46
Engineers Gate Manager
New York
$132K +$35.7K +4,900 +23%
Goldman Sachs
47
Goldman Sachs
New York
$126K +$182K +24,959 New
GCP
48
GSA Capital Partners
United Kingdom
$113K +$56.6K +7,780 +53%
Northern Trust
49
Northern Trust
Illinois
$109K -$458 -63 -0.3%
D.E. Shaw & Co
50
D.E. Shaw & Co
New York
$103K -$553K -76,072 -79%
1
2
3 4

AVDL Hedge Fund Activity: Q3 2020 in Review

79 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q3 2020, worth a combined $156M — down 47% from $293M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new AVDL positions and 15 closed out — a net gain of 5 holders — while 25 added to existing stakes and 19 trimmed.

The largest buyer was Brandes Investment Partners, adding an estimated $9.87M. The largest seller was RA Capital Management, exiting entirely with an estimated $25.3M sold.

  • 79 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q3 2020, up from 74 in Q2 2020.
  • Funds reported $156M of Avadel Pharmaceuticals stock for Q3 2020, down 47% quarter-over-quarter.
  • 20 funds opened new Avadel Pharmaceuticals positions in Q3 2020 and 15 closed out, a net change of +5 holders.
  • The largest Avadel Pharmaceuticals buyer in Q3 2020 was Brandes Investment Partners, an estimated $9.87M added.
  • The largest Avadel Pharmaceuticals seller in Q3 2020 was RA Capital Management, an estimated $25.3M sold.

Based on aggregated 13F filings for Q3 2020.